This paper evaluated potential changes in plasma levels of 27 proteins following three years of frozen storage and multiple freeze-thaw cycles in case-matched specimens from colorectal cancer (CRC) patients. The potential for differential protein expression between patients with CRC and those without cancer was also investigated as was the correlation in diagnostic performance between the two measurements.
Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze-Thaw Cycles Apart.
Bhardwaj M, Schrotz-King P, Brenner H
Purpose
Conclusion
Levels of all the 27 proteins evaluated were moderately to strongly correlated between plasma that was stored for three years at -80°C and experienced multiple freeze-thaw cycles and pre-storage levels of the same samples (R=0.43-0.97, P<0.01, all). Six proteins were differentially expressed in plasma from CRC patients compared to patients without neoplasms, five of which remained significant after correction for multiple testing. While the area under the curve (AUC) for 26 of the 27 proteins evaluated was modestly correlated between plasma stored at -80°C for 3 years and the same samples analyzed prior to storage, the AUC of WAP four-disulfide core domain protein 2 (WFDC2) displayed a significant difference between the two measurements.
Studies (1)
Purpose
This study investigated the levels of 27 proteins in plasma specimens from CRC patients prior to storage and after storage for three years at -80°C and multiple freeze-thaw cycles. The authors also investigated expression of these markers in CRC relative to patients without cancer and correlated diagnostic performance between pre- and post-storage measurements. Pre-diagnostic EDTA blood specimens were collected at 20 gastroenterological practices one week prior to a screening colonoscopy from 39 patients diagnosed with colorectal cancer (mean age 67 years) and 181 patients without cancer (mean 62 years) in 2015, and from an additional 102 patients without cancer (mean 65.5 years) in 2018. Specimens were transported to the laboratory and plasma was isolated by centrifugation at 2000-2500 g for 10 min at 4°C and then stored at -80°C for an unspecified duration prior to initial analysis. Plasma from patients with CRC were stored at -80°C for an average of 3 years with 3 freeze-thaw cycles before reanalysis. Protein concentrations were measured by proximity extension assay with the Olink Proseek Mulitplex Oncology I panel in 2015, and with the Olink Proseek Mulitplex Oncology I panel in 2018. Analysis was limited to the 27 proteins included in both panels.
Summary of Findings
Levels of the 27 proteins evaluated were modestly to strongly correlated between the measurements (R=0.43-0.97, P<0.01, all). The strongest correlations (R>0.8, P<0.0005) were observed for carcinoembryonic antigen (CEA), carbonic anhydrase (CAIX), Fas-associated death domain protein (FADD), interleukin-6 (IL6), mucin-16 (MUC16), amphiregulin (AREG), transforming growth factor alpha (TGFalpha), and vimentin (VIM). Six proteins displayed differential expression in plasma from CRC patients versus those without neoplasms of which five remained after correction for multiple testing. The area under the curve was ≥0.7 for AREG and CEA. The AUC was correlated between measurements in 2015 and 2018 (R=0.58) and only the AUC of WAP four-disulfide core domain protein 2 (WFDC2) displayed a significant difference between measurements.
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNormalNot specifiedPlatforms
ProteinImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition CRCNot diagnosed with cancerStorage Freeze/thaw cycling 1 cycleMultiple cyclesStorage Storage duration Mean of 3 yearsNone